Cancel
Known information
- Holds a PhD in macromolecular and cellular structure and chemistry from The Scripps Research Institute
- Completed post-doctoral work at the Skirball Institute of Biomolecular Medicine at NYU Langone School of Medicine
- Previously worked as Senior Director, Discovery Technologies at UNITY Biotechnology
- Was Director of Biotechnology at Sapphire Energy
- Led the bioinformatics function at Favrille, a clinical-stage company developing patient-specific cancer vaccines for Non-Hodgkin lymphoma
- Earned a BS in biomedical engineering from Northwestern University
About TRex Bio
TRex Bio is a biotechnology company that develops treatments for immune-mediated diseases using a human tissue-based platform combined with machine learning and high-throughput '-omics'.
Report inaccurate information
